SCHEMBL3167111

SCHEMBL3167111

O=C(Cc1c(F)cc2ncc(Br)cc2c1F)NNC(=S)S.[KH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163353 0.99
Potassium SCHEMBL3167125 0.98
Potassium Ion SCHEMBL3167116 0.89 CDK5 (0.32)
SCHEMBL3162336 0.82 PLA2G2A (0.35)
SCHEMBL3161846 0.81 MET (0.39)
SCHEMBL3158179 0.79 MET (0.40)
SCHEMBL3589699 0.79 AURKA (0.39)
Potassium SCHEMBL3161871 0.78 MET (0.39)
SCHEMBL3149520 0.77 TSHR (0.36)
SCHEMBL12101260 0.64 AGBL2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2162132-A1 HETEROCYCLIC KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2010-03-17 EP disclosed
US-20090156594-A1 HETEROCYCLIC KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2009-06-18 US disclosed
WO-2008144767-A1 HETEROCYCLIC KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-11-27 WO disclosed